A novel oral nutraceutical formula of omega-3 and omega-6 fatty acids with vitamins (PLP10) in relapsing remitting multiple sclerosis: a randomised, double-blind, placebo-controlled proof-of-concept clinical trial
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • A rapid response is a moderated but not peer reviewed online response to a published article in a BMJ journal; it will not receive a DOI and will not be indexed unless it is also republished as a Letter, Correspondence or as other content. Find out more about rapid responses.
  • We intend to post all responses which are approved by the Editor, within 14 days (BMJ Journals) or 24 hours (The BMJ), however timeframes cannot be guaranteed. Responses must comply with our requirements and should contribute substantially to the topic, but it is at our absolute discretion whether we publish a response, and we reserve the right to edit or remove responses before and after publication and also republish some or all in other BMJ publications, including third party local editions in other countries and languages
  • Our requirements are stated in our rapid response terms and conditions and must be read. These include ensuring that: i) you do not include any illustrative content including tables and graphs, ii) you do not include any information that includes specifics about any patients,iii) you do not include any original data, unless it has already been published in a peer reviewed journal and you have included a reference, iv) your response is lawful, not defamatory, original and accurate, v) you declare any competing interests, vi) you understand that your name and other personal details set out in our rapid response terms and conditions will be published with any responses we publish and vii) you understand that once a response is published, we may continue to publish your response and/or edit or remove it in the future.
  • By submitting this rapid response you are agreeing to our terms and conditions for rapid responses and understand that your personal data will be processed in accordance with those terms and our privacy notice.
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

Other responses

  • Published on:
    Almond as a potential nutritional supplement in patients with multiple sclerosis-associated fatigue
    • Mehdi Sardari
    • Other Contributors:
      • Bagher Minaei, Hossein Rezaeizadeh, Mohammad Kamalinejad

    The result of the study presented by Dr. MC Pantzaris and colleagues showed the efficacy of a formulations containing omga-3, omega-6 and vitamin A and -E in relapsing-remitting multiple sclerosis (RR-MS). We want to discuss here on potential benefits of almond as a natural source of these nutritional elements, and other previously shown beneficial nutritional elements in patients with MS and fatigue. Multiple Sclerosis...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Re:Omega-3, omega-6 and vitamin treatment for relapsing-remitting multiple sclerosis

    Response by the authors:

    On behalf of the PLP10 study co-authors (1), Ioannis S Patrikios, George N Loukaides and Mario C Pantzaris, I report our opinion and response to the e-letter "Omega-3, omega-6 and vitamin treatment for relapsing-remitting multiple sclerosis" by Oivind Torkildsen. We really appreciate the comments by Dr Oivind Torkildsen (2) and we thank him for giving us the chance to clarify more on th...

    Show More
    Conflict of Interest:
    None declared.
  • Published on:
    Omega-3, omega-6 and vitamin treatment for relapsing-remitting multiple sclerosis
    • Oivind Torkildsen, MD, PhD
    • Other Contributors:
      • Trygve Holmoy, Kristin Loken-Aamsrud, Kjell-Morten Myhr, Stig Wergeland

    Dr. Pantzaris and colleagues (1) have recently performed a study on a dietary intervention consisting of omga-3, omega-6 and vitamin A and -E in various formulations in relapsing-remitting multiple sclerosis (RR-MS). The authors suggested that a special combination of omega-3, omega-6 and fat soluble vitamins could have profound effects on magnetic resonance (MR) disease activity and disease progression. The main problem i...

    Show More
    Conflict of Interest:
    None declared.